Gwendolyn K. Binder's most recent trade in Instil Bio Inc was a trade of 6,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Instil Bio Inc | Gwendolyn K. Binder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 176,000 | 176,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 176,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 160,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 130,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 66,667 | 66,667 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 66,667 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 29,908 | 29,908 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 29,908 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 145,000 | 145,000 | - | - | Stock Option (Right to Buy) | |
Instil Bio Inc | Gwendolyn K. Binder-Scholl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) |